KR20240167935A - 외상성 뇌 손상의 바이오마커 - Google Patents

외상성 뇌 손상의 바이오마커 Download PDF

Info

Publication number
KR20240167935A
KR20240167935A KR1020247037409A KR20247037409A KR20240167935A KR 20240167935 A KR20240167935 A KR 20240167935A KR 1020247037409 A KR1020247037409 A KR 1020247037409A KR 20247037409 A KR20247037409 A KR 20247037409A KR 20240167935 A KR20240167935 A KR 20240167935A
Authority
KR
South Korea
Prior art keywords
mir
hsa
mirna
tbi
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247037409A
Other languages
English (en)
Korean (ko)
Inventor
안토니오 벨리
피에트로 발렌티나 디
Original Assignee
더 유니버시티 오브 버밍험
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 유니버시티 오브 버밍험 filed Critical 더 유니버시티 오브 버밍험
Publication of KR20240167935A publication Critical patent/KR20240167935A/ko
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
KR1020247037409A 2016-03-08 2017-01-30 외상성 뇌 손상의 바이오마커 Pending KR20240167935A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1603967.9A GB201603967D0 (en) 2016-03-08 2016-03-08 Biomarkers of traumatic brain injury
GB1603967.9 2016-03-08
PCT/GB2017/050231 WO2017153710A1 (en) 2016-03-08 2017-01-30 Biomarkers of traumatic brain injury
KR1020187026295A KR102729795B1 (ko) 2016-03-08 2017-01-30 외상성 뇌 손상의 바이오마커

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020187026295A Division KR102729795B1 (ko) 2016-03-08 2017-01-30 외상성 뇌 손상의 바이오마커

Publications (1)

Publication Number Publication Date
KR20240167935A true KR20240167935A (ko) 2024-11-28

Family

ID=55859162

Family Applications (4)

Application Number Title Priority Date Filing Date
KR1020247037409A Pending KR20240167935A (ko) 2016-03-08 2017-01-30 외상성 뇌 손상의 바이오마커
KR1020187026295A Active KR102729795B1 (ko) 2016-03-08 2017-01-30 외상성 뇌 손상의 바이오마커
KR1020197022615A Active KR102618993B1 (ko) 2016-03-08 2017-12-22 외상성 뇌 손상의 바이오마커
KR1020237044544A Pending KR20240011189A (ko) 2016-03-08 2017-12-22 외상성 뇌 손상의 바이오마커

Family Applications After (3)

Application Number Title Priority Date Filing Date
KR1020187026295A Active KR102729795B1 (ko) 2016-03-08 2017-01-30 외상성 뇌 손상의 바이오마커
KR1020197022615A Active KR102618993B1 (ko) 2016-03-08 2017-12-22 외상성 뇌 손상의 바이오마커
KR1020237044544A Pending KR20240011189A (ko) 2016-03-08 2017-12-22 외상성 뇌 손상의 바이오마커

Country Status (14)

Country Link
US (5) US20190085395A1 (enExample)
EP (7) EP4403649A3 (enExample)
JP (5) JP7111619B2 (enExample)
KR (4) KR20240167935A (enExample)
CN (4) CN116004796A (enExample)
AU (3) AU2017231845B2 (enExample)
CA (2) CA3015150A1 (enExample)
ES (4) ES2967073T3 (enExample)
GB (1) GB201603967D0 (enExample)
NZ (1) NZ782016A (enExample)
PL (2) PL3712277T3 (enExample)
UA (1) UA127918C2 (enExample)
WO (2) WO2017153710A1 (enExample)
ZA (1) ZA201805982B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3800267A1 (en) 2014-03-27 2021-04-07 Yale University Circulating micrornas as biomarkers for endometriosis
GB201603967D0 (en) 2016-03-08 2016-04-20 Univ Birmingham Biomarkers of traumatic brain injury
EP3506912B1 (en) * 2016-08-30 2024-04-03 Yale University Micrornas as biomarkers for endometriosis
WO2018175941A1 (en) * 2017-03-23 2018-09-27 Quadrant Biosciences Inc. Analysis and prediction of traumatic brain injury and concusion symptoms
US11739323B2 (en) * 2017-06-08 2023-08-29 Temple University-Of The Commonwealth System Of Higher Education Micro-RNAs as biomarkers for subconcussive and concussive injury and therapeutic applications
CN112424606B9 (zh) * 2018-05-31 2025-03-07 阿米达斯公司 用于检测创伤性脑损伤的组合物和方法
SG10201807529VA (en) * 2018-09-03 2020-04-29 Nec Asia Pacific Pte Ltd Systems and methods for predicting recovery of a patient
US11315660B2 (en) 2018-10-31 2022-04-26 Dot Laboratories, Inc. Method of detecting and treating endometriosis in a female subject
PL3924518T3 (pl) 2019-02-14 2025-08-11 Marker Diagnostics Uk Limited Obecne w ślinie biomarkery urazu mózgu
KR102184840B1 (ko) * 2019-05-20 2020-11-30 이화여자대학교 산학협력단 외상 후 스트레스 장애 진단 또는 예측용 바이오마커 및 그의 용도
US11965879B2 (en) * 2019-08-23 2024-04-23 Mcmaster University Method for diagnosing and assessing endometriosis
KR102272915B1 (ko) 2019-09-27 2021-07-06 주식회사 이지다이아텍 새로운 외상성 뇌손상 및 감염병 poct 진단시스템
CN110684835A (zh) * 2019-10-12 2020-01-14 山东大学齐鲁医院 miR-21在诊治蛛网膜下腔出血中的应用
CN111419866A (zh) * 2020-03-02 2020-07-17 南通大学 miR-29a-3p在制备治疗周围神经损伤药物中的应用
US12157918B2 (en) * 2020-09-04 2024-12-03 University Of Kentucky Research Foundation Clinical assessment of cerebral vasospasm risk following aneurysmal subarachnoid hemorrhage
AU2022247502A1 (en) 2021-04-02 2023-11-16 Marker Holdings Ag Biomarkers of musculoskeletal injury
CN116219019A (zh) * 2023-03-02 2023-06-06 圣湘生物科技股份有限公司 一种用于结直肠癌诊断的microRNA标志物组合物及检测试剂、检测试剂盒
KR20240167411A (ko) 2023-05-19 2024-11-26 주식회사 이지다이아텍 자동 항체 커플링 및 이를 확인하는 장치
WO2025039033A1 (en) * 2023-08-21 2025-02-27 Glia Diagnostics Pty Ltd Methods and reagents for diagnosis and/or prognosis of traumatic brain injury

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH31414A (en) 1994-02-24 1998-10-29 Boehringer Ingelheim Int Method of diagnosing cancer precancerous state, orsusceptibility to other forms of diseases by anal ysis of irf-1 specific rna in biopsy samples.
RU2207626C2 (ru) 1997-12-18 2003-06-27 Инфинеон Текнолоджиз Аг Устройство для съемки изображений
RU66524U1 (ru) 2007-05-03 2007-09-10 Федор Андреевич Егоров Сооружение, в котором обеспечена возможность комплексного мониторинга сооружения
CN101424640B (zh) 2007-11-02 2012-07-25 江苏命码生物科技有限公司 血清中微小核糖核酸的检测方法和用于检测的试剂盒、生物芯片及其制作和应用方法
DE102008017652A1 (de) 2008-04-04 2009-10-08 Leonhard Kurz Stiftung & Co. Kg Sicherheitselement sowie Verfahren zur Herstellung eines Sicherheitselements
EP2336353A1 (en) 2009-12-17 2011-06-22 febit holding GmbH miRNA fingerprints in the diagnosis of diseases
JP5909447B2 (ja) * 2009-09-14 2016-04-26 バンヤン・バイオマーカーズ・インコーポレーテッド ニューロン損傷診断のためのマイクロrna、自己抗体およびタンパク質マーカー
RU93660U1 (ru) 2010-02-08 2010-05-10 Государственное образовательное учреждение высшего профессионального образования "Ростовский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО "РостГМУ Росздрава") Тест-полоска для диагностики нефропатии
CN103237901B (zh) * 2010-03-01 2016-08-03 卡里斯生命科学瑞士控股有限责任公司 用于治疗诊断的生物标志物
EP2839005B1 (en) * 2012-04-20 2021-01-06 Aptamir Therapeutics, Inc. Mirna modulators of thermogenesis
WO2014004889A2 (en) 2012-06-27 2014-01-03 Musc Foundation For Research Development Plasma analytes predict diagnosis and prognosis of thoracic aortic aneurysm
GB201223243D0 (en) * 2012-12-21 2013-02-06 King S College London Detection method
CA2939692C (en) 2013-03-15 2022-10-18 The Trustees Of The University Of Pennsylvania Blood biomarkers that predict persistent cognitive dysfunction after concussion
US9890428B2 (en) * 2013-05-14 2018-02-13 Ohio State Innovation Foundation MiRNA biomarkers for radiation biodosimetry
US9434945B2 (en) * 2013-08-02 2016-09-06 University Of Maryland, Baltimore Use of miR-23a-3p and/or miR-27a-3p mimics as therapeutic agents for inhibition of neuronal apoptosis following brain injury
CN103667445A (zh) * 2013-10-16 2014-03-26 石磊 一种脑梗塞早期诊断标志物及其应用
ES2813699T3 (es) * 2013-11-18 2021-03-24 Diamir Llc Métodos de uso de miARN de fluidos corporales para la detección y monitoreo de la enfermedad de Parkinson (PD)
JP6468609B2 (ja) * 2014-02-26 2019-02-13 フィリップス ライティング ホールディング ビー ヴィ 光の反射に基づく検出
WO2015134551A1 (en) * 2014-03-03 2015-09-11 Banyan Biomarkers, Inc. Micro rna markers for diagnosis of a neurological condition
US9605315B2 (en) * 2014-03-26 2017-03-28 The University Of Montana Detection of traumatic brain injury
WO2015153864A2 (en) 2014-04-02 2015-10-08 Hopkins Patricia T Methods for treating inflammatory conditions
EP3134552B1 (en) * 2014-04-22 2020-11-18 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. Methods, processes, devices and kits for the measurement of post traumatic stress disorder microrna markers
WO2015196191A1 (en) * 2014-06-20 2015-12-23 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Microrna biomarkers for traumatic brain injury and methods of use thereof
ES2558262B2 (es) 2014-08-01 2016-07-14 Universidad Católica De Valencia "San Vicente Mártir" Método de diagnóstico de fibromialgia basado en microRNAs
CN104293791B (zh) * 2014-10-22 2018-01-12 首都医科大学附属北京友谊医院 miR‑200b在制备Rac‑1蛋白表达抑制剂中的新用途
EP3329005B1 (en) * 2015-07-29 2020-05-13 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. Microrna biomarkers for traumatic brain injury and methods of use thereof
WO2017044650A1 (en) 2015-09-08 2017-03-16 The Translational Genomics Research Institute Biomarkers and methods of diagnosing and prognosing mild traumatic brain injuries
GB201603967D0 (en) 2016-03-08 2016-04-20 Univ Birmingham Biomarkers of traumatic brain injury
WO2018175941A1 (en) 2017-03-23 2018-09-27 Quadrant Biosciences Inc. Analysis and prediction of traumatic brain injury and concusion symptoms
EP3601564A4 (en) 2017-03-23 2021-03-31 Quadrant Biosciences Inc. PROCESS FOR DIAGNOSING OR MONITORING CONDITIONS CHARACTERIZED BY ABNORMAL TEMPORAL VARIATIONS, PROCESS FOR NORMALIZING EPIGENETIC DATA TO COMPENSATE FOR TEMPORAL VARIATIONS
PL3924518T3 (pl) 2019-02-14 2025-08-11 Marker Diagnostics Uk Limited Obecne w ślinie biomarkery urazu mózgu

Also Published As

Publication number Publication date
AU2025263788A1 (en) 2025-11-27
WO2018138468A1 (en) 2018-08-02
CN116004796A (zh) 2023-04-25
EP3574117A1 (en) 2019-12-04
CN109415769A (zh) 2019-03-01
EP3712277C0 (en) 2024-06-12
EP3574117B1 (en) 2023-08-16
US20180127828A1 (en) 2018-05-10
EP3712277B1 (en) 2024-06-12
EP4257705C0 (en) 2025-04-23
EP4257705A2 (en) 2023-10-11
EP4257705B1 (en) 2025-04-23
JP7413455B2 (ja) 2024-01-15
KR20190111967A (ko) 2019-10-02
EP4257705A3 (en) 2024-01-17
CN118441040A (zh) 2024-08-06
WO2017153710A1 (en) 2017-09-14
CA3015150A1 (en) 2017-09-14
JP7132224B2 (ja) 2022-09-06
JP7111619B2 (ja) 2022-08-02
US20190085395A1 (en) 2019-03-21
ZA201805982B (en) 2022-01-26
US10563262B2 (en) 2020-02-18
ES2967073T3 (es) 2024-04-25
NZ782016A (en) 2025-07-25
KR20180118670A (ko) 2018-10-31
UA127918C2 (uk) 2024-02-14
EP4403649A2 (en) 2024-07-24
EP3712280A1 (en) 2020-09-23
US12467095B2 (en) 2025-11-11
EP4582559A3 (en) 2025-10-08
RU2018135107A (ru) 2020-04-08
RU2018135107A3 (enExample) 2020-12-14
ES2987237T3 (es) 2024-11-14
EP4403649A3 (en) 2024-10-30
BR112018067882A2 (pt) 2019-02-05
PL3712277T3 (pl) 2025-02-10
CN110291210B (zh) 2024-05-28
EP4582559A2 (en) 2025-07-09
JP2022163063A (ja) 2022-10-25
GB201603967D0 (en) 2016-04-20
ES2965297T3 (es) 2024-04-12
NZ745808A (en) 2024-09-27
EP3712280B8 (en) 2023-09-13
AU2017231845B2 (en) 2023-09-28
HK1258615A1 (zh) 2019-11-15
JP2024041804A (ja) 2024-03-27
CN110291210A (zh) 2019-09-27
KR102729795B1 (ko) 2024-11-14
EP3712277A1 (en) 2020-09-23
PL4257705T3 (pl) 2025-08-18
CN109415769B (zh) 2022-09-30
EP3426796A1 (en) 2019-01-16
AU2023282212B2 (en) 2025-10-16
KR20240011189A (ko) 2024-01-25
US11414705B2 (en) 2022-08-16
EP3426796B1 (en) 2023-09-06
JP2019509044A (ja) 2019-04-04
EP3712280B1 (en) 2023-08-09
US20230313300A1 (en) 2023-10-05
CA3050996A1 (en) 2018-08-02
AU2017231845A1 (en) 2018-09-13
JP7654769B2 (ja) 2025-04-01
US20200385808A1 (en) 2020-12-10
JP2020511953A (ja) 2020-04-23
KR102618993B1 (ko) 2023-12-28
US20230295726A1 (en) 2023-09-21
AU2023282212A1 (en) 2024-01-04
ES3032995T3 (en) 2025-07-29
JP2025098112A (ja) 2025-07-01

Similar Documents

Publication Publication Date Title
US20230313300A1 (en) Biomarkers of traumatic brain injury
HK40095431A (en) Biomarkers of traumatic brain injury
RU2771757C2 (ru) Биомаркеры травматического повреждения головного мозга
HK40114018A (en) Biomarkers of traumatic brain injury
HK40034626A (en) Biomarkers of severe traumatic brain injury
HK40034626B (en) Biomarkers of severe traumatic brain injury
HK1258615B (en) Biomarkers of traumatic brain injury
HK40011329A (en) Biomarkers of traumatic brain injury
HK40011329B (en) Biomarkers of traumatic brain injury
OA19460A (en) Biomarkers of traumatic brain injury.

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20241108

Application number text: 1020187026295

Filing date: 20180911

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20241206

Comment text: Request for Examination of Application